LOGOFARMA S.p.A. is an Italian pharmaceutical company established in 2011, dedicated to the study and commercialization of products for the prevention and treatment of dermatological conditions.

Company Profile

Headquarters:
Milan, Italy.

Specialization:
Dermatology and aesthetic medicine.

Mission:
To develop and supply innovative, safe, and effective formulations (pharmaceuticals, medical devices, food supplements, and cosmetics) that enhance the appearance and well-being of the skin and its appendages, thereby improving patients’ quality of life.

Network:
Logofarma is part of an international network of European companies, collaborating with Boderm lab in Athens for R&D and production, and distributing products in 11 European countries.

Market Approach:
The company employs a qualified network of scientific pharmaceutical representatives who periodically visit specialist doctors and students at national dermatology schools across Italy, consolidating partnerships with specialists in Dermatology, Plastic Surgery, and Aesthetic Medicine.

Product Focus

LOGOFARMA’s product portfolio targets a wide range of skin issues:

Inflammatory Conditions:
Solutions for psoriasis, acne, seborrheic dermatitis, atopic dermatitis, radiodermatitis, and oxidative stress.

Infections:
Products addressing fungal, yeast, mold, and bacterial skin infections.

Hair and Scalp:
Treatments for androgenetic alopecia (hair loss), pruritus, and general scalp dryness/dandruff.

Aesthetic Concerns:
Products for rosacea, couperose, scars, and skin spots.

Pain Management:
Anesthetics for minor skin surgery or venipuncture in children.